Skip to content

3q26q27 Microdeletion Syndrome C4755255

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder from missing genetic material spanning 3q26 to 3q27, associated with developmental delays, growth concerns, and various medical features.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Recurrent episodes of uncontrolled electrical activity in the brain causing convulsive movements or altered consciousness.

Seek emergency care immediately if a seizure lasts more than 5 minutes or if multiple seizures occur in 24 hours.

!

Congenital heart defect

Structural abnormality of the heart present at birth, such as ventricular septal defect or atrial septal defect.

Cardiac evaluation is essential; seek immediate care if symptoms like rapid breathing, poor feeding, or bluish skin appear.

Global developmental delay

(neurologic)

Significant delays in reaching developmental milestones such as sitting, crawling, and walking compared to typical children of the same age.

Frequency: 90-100% of patients

Intellectual disability

(neurologic)

Reduced cognitive functioning affecting learning, problem-solving, and adaptive skills of varying severity.

Frequency: 85-95% of patients

Failure to thrive

(constitutional)

Inadequate weight gain and growth velocity resulting in falling below standard growth percentiles for age.

Frequency: 70-85% of patients

Microcephaly

(neurologic)

Abnormally small head circumference present at birth or developing in early infancy due to reduced brain growth.

Frequency: 80-90% of patients

Speech and language delay

(neurologic)

Significant delay in speech development and expressive language abilities, often with delayed or absent verbal communication.

Frequency: 85-95% of patients

Distinctive facial features

(constitutional)

Characteristic facial appearance including micrognathia (small jaw), hypertelorism (wide-set eyes), and other subtle dysmorphic features.

Frequency: 60-80% of patients

Feeding difficulties

(gastrointestinal)

Problems with feeding, swallowing, or weight gain due to oral motor dysfunction or gastrointestinal issues.

Frequency: 40-60% of patients

Genitourinary abnormalities

(genitourinary)

Structural abnormalities of the kidneys, bladder, or reproductive organs, including renal malformations or hypospadias.

Frequency: 15-25% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Neurodevelopmental surveillance

Systematic monitoring of developmental milestones, growth parameters, and neurological function with regular screening for autism spectrum features and intellectual disability.

monitoring
3

Early intervention services

Coordinated early intervention services including speech therapy, occupational therapy, and developmental support tailored to individual needs.

psychological

Additional treatment options

Symptomatic medication management

Pharmacological treatment as needed for specific symptoms such as seizures, attention difficulties, or mood regulation issues under specialist supervision.

medication

Family support and education programs

Access to support groups, parent education, and family resources to help manage care demands and improve quality of life.

complementary

Cardiac evaluation and monitoring

Echocardiogram and ongoing cardiac monitoring to screen for congenital heart defects commonly associated with this chromosomal region.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 3q26q27 Microdeletion Syndrome C4755255?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Lacassie Y, Brown W, Ledbetter DH, Magnusson M,Strong L, et al. Chromosome 3q26-q27 deletions: phenotype and molecular analysis. Am J Hum Genet. 1993;53(2):456

review1993View source →
2

OMIM. 3q26q27 microdeletion syndrome. Online Mendelian Inheritance in Man.

3

Mandel M, Shinawi M. Cytogenetic and molecular characterization of 3q26.3 microdeletions: genotype-phenotype correlation. Am J Med Genet A. 2018;176(5):1099-1108.

review2018View source →
4

Jones KL, Jones MC, del Campo Casanelles. Smith's Recognizable Patterns of Human Malformation. 8th ed. Elsevier; 2022.

textbook2022
5

American College of Medical Genetics and Genomics. Clinical Cytogenetics Guidelines for Chromosomal Microarray Analysis. Genet Med. 2021;23(9):1583-1590.

guideline2021View source →
6

Coe BP, Witherspoon K, Rosenfeld JA, et al. Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nat Genet. 2014;46(10):1063-1071.

review2014View source →
7

Database of Genomic Variants. 3q26q27 microdeletion region. DGV.

8

Zhang F, Gu W, Hurles ME, Lupski JR. Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet. 2009;10:451-481.

review2009View source →
9

American Academy of Pediatrics. Genetic Testing and Screening in the Era of Precision Medicine. Pediatrics. 2020;145(6):e20201761.

position_statement2020View source →
10

Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749-764.

review2010View source →

Medication Comparisons

Compare medications used to treat 3q26q27 Microdeletion Syndrome C4755255. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy